Clinical Trial Update: Maintaining Suppression of Testosterone With Transdermal Estradiol Gel [Phase 2]

View source ↗

Summary

Phase 2 trial update on maintaining suppression of testosterone with transdermal estradiol gel in prostate cancer; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• transdermal estradiol gel (estradiol)

Snippet

Sponsor: BHR Pharma, LLC | Conditions: Cancer of the Prostate | Phase 2 | Status: TERMINATED | Results posted: 2022-03-31